Stocksigma LogoStocksigma Logo

Lupin Secures U.S. FDA Approval for Generic Modafinil Tablets

Lupin Limited received U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP (100 mg and 200 mg) on 4th Sep'26

Lupin Secures U.S. FDA Approval for Generic Modafinil Tablets

Lupin Ltd 路 Press Release 路 04 Sept 2026, 11:12 pm

Lupin Secures U.S. FDA Approval for Generic Modafinil Tablets Lupin Limited received U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP (100 mg and 200 mg) on 4th Sep'26. The product is a generic equivalent of Nuvo Pharmaceuticals' Provigil Tablets, indicated to improve wakefulness in adults with excessive sleepiness from narcolepsy, obstructive sleep apnea, or shift work disorder. According to IQVIA MAT Jul'26 data, Modafinil Tablets had estimated annual sales of USD 70.7 million in the U.S. market.

Original exchange filing (PDF)

More announcements from Lupin Ltd

All Lupin Ltd announcements